Upstream Bio (NASDAQ:UPB) shares rallied 32% Friday following the asthma drug developer’s $255M upsized initial public ...

Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest ...

Three U.S. healthcare startups priced their initial public offerings (IPO) on Thursday, including Upstream Bio which raised ...

Two biotechs set out for the public markets this week, with Upstream Bio raising $255 million for its inflammatory disease ...

Shares of Upstream Bio opened 26.5% above the initial public offering price in their Nasdaq debut on Friday, valuing the drug developer at $1.05 billion.

Three US life-sciences companies hitting the market delivered mostly robust early trading after investors strongly supported ...

By Arasu Kannagi Basil (Reuters) -Shares of Upstream Bio opened 26.5% above the initial public offering price in their Nasdaq debut on Friday, valuing the drug developer at $1.05 billion. The robust ...

CeriBell (CBLL) shares rallied 35% Friday following the medical device maker’s $180M initial public offering. Read more here.

This summary provides a snapshot of current health news, including IPO pricing by biotech startups, Sanofi's potential sale of its consumer health business, HMI Medical's acquisition in Singapore, a ...

Three US life-sciences companies have so far exceeded or met their goals in initial public offerings Thursday, showing ...

The average IG bond spread edged in by 1bp to 84bp, a record post financial crisis low, on Thursday, and the HY bond spread gapped out by 5bp to 299bp, according to ICE BofA data.